Literature DB >> 17662778

Risk factors affecting outcome and morbidity in the surgical management of bronchiectasis.

Sevval Eren1, Hidir Esme, Alper Avci.   

Abstract

OBJECTIVE: Bronchiectasis continues to be a major cause of morbidity and mortality in developing countries. The purpose of this study was to present the results of our 14 years of surgical experience to re-evaluate our indications for using surgical therapy and to analyze several factors that might affect the outcome and postoperative complications of this disease.
METHOD: Age, sex, etiologic factors, symptoms, the duration of symptoms, radiologic and radionuclide examinations, preoperative evaluation, surgical procedures, postoperative morbidity and mortality, and the follow-up results from 143 patients operated on for bronchiectasis between January 1992 and January 2006, were reviewed retrospectively.
RESULTS: One hundred forty-three patients underwent 148 operations for bronchiectasis. The mean age was 23.4 years. Complete resection was achieved in 118 patients. The morbidity rate was 23.0% and the mortality rate was 1.3%. Postoperatively, 75.9% of the patients were free of symptoms, 15.7% were improved, and 8.2% showed no improvement or were worse. The logistic regression analysis showed that a history of tuberculosis and incomplete resection were independent predictors of the operative result. Moreover, the lack of a preoperative bronchoscopic examination, a forced expiratory volume in 1 second of less than 60% of the predicted value, a history of tuberculosis, and incomplete resection were independent predictors of postoperative complications.
CONCLUSIONS: A history of tuberculosis and incomplete resection were risk factors both for postoperative complications and for a worse operative result. The lack of a preoperative bronchoscopic examination and a low forced expiratory volume in 1 second were risk factors for postoperative complications. Surgery for multiple segments on different lobes should be performed whenever possible.

Entities:  

Mesh:

Year:  2007        PMID: 17662778     DOI: 10.1016/j.jtcvs.2007.04.024

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

Review 1.  Surgical management of non-cystic fibrosis bronchiectasis.

Authors:  Miyako Hiramatsu; Yuji Shiraishi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Surgical management of bronchiectasis: the indications and outcomes.

Authors:  Soner Gursoy; Ali Ata Ozturk; Ahmet Ucvet; Ahmet Emin Erbaycu
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

Review 3.  Bronchiectasis.

Authors:  Nick Ht Ten Hacken; Huib Am Kerstjens
Journal:  BMJ Clin Evid       Date:  2011-08-16

Review 4.  Bronchiectasis.

Authors:  Cecile Magis-Escurra; Monique He Reijers
Journal:  BMJ Clin Evid       Date:  2015-02-25

5.  Surgery for bronchiectasis: The effect of morphological types to prognosis.

Authors:  Ufuk Cobanoglu; Irfan Yalcinkaya; Metin Er; Ahmet Feridun Isik; Fuat Sayir; Duygu Mergan
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

6.  A long-term study assessing the factors influencing survival and morbidity in the surgical management of bronchiectasis.

Authors:  Abidin Sehitogullari; Salim Bilici; Fuat Sayir; Ufuk Cobanoglu; Ali Kahraman
Journal:  J Cardiothorac Surg       Date:  2011-12-11       Impact factor: 1.637

Review 7.  Efficiency and safety of surgical intervention to patients with Non-Cystic Fibrosis bronchiectasis: a meta-analysis.

Authors:  Li-Chao Fan; Shuo Liang; Hai-Wen Lu; Ke Fei; Jin-Fu Xu
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

8.  Bronchiectasis: Experience of Surgical Management at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

Authors:  Berhanu Nega; Yonas Ademe; Ayalew Tizazu
Journal:  Ethiop J Health Sci       Date:  2019-07

9.  Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis.

Authors:  A B Chang; C A Byrnes; M L Everard
Journal:  Paediatr Respir Rev       Date:  2010-12-04       Impact factor: 2.726

Review 10.  Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis.

Authors:  Sherstin T Lommatzsch
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.